Saquinavir (Roche protease inhibitor) at higher doses.
D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial / Q000235:genetics; D015658:HIV Infections; D016333:HIV Protease / Q000235:genetics; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D008111:Liver Function Tests; D009154:Mutation; D009503:Neutropenia / Q000139:chemically induced; D011804:Quinolines / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D019258:Saquinavir
D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D016333:HIV Protease; D019258:Saquinavir